Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

C4 Therapeutics Inc (CCCC)

C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

C4 Therapeutics Inc 490 Arsenal Way Suite 120 Watertown MA 02472 USA

www.c4therapeutics.com Employees: 145 P: 617-231-0700

Description:

C4 Therapeutics Inc. is a biopharmaceutical company. It is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc. is based in WATERTOWN, Mass.

Key Statistics

Overview:

Market Capitalization, $K 388,986
Enterprise Value, $K 262,396
Shares Outstanding, K 69,338
Annual Sales, $ 20,760 K
Annual Net Income, $ -132,490 K
Last Quarter Sales, $ 12,010 K
Last Quarter Net Income, $ -17,720 K
EBIT, $ -118,900 K
EBITDA, $ -120,400 K
60-Month Beta 3.04
% of Insider Shareholders 8.55%
% of Institutional Shareholders 78.81%
Float, K 63,410
% Float 91.45%
Short Volume Ratio 0.52

Growth:

1-Year Return 313.46%
3-Year Return -87.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 08/01/24
Next Earnings Date 11/06/24 [--]
Earnings Per Share ttm -1.90
EPS Growth vs. Prev Qtr -34.62%
EPS Growth vs. Prev Year 36.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CCCC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.12%
Return-on-Assets % -27.38%
Profit Margin % -638.20%
Debt/Equity 0.00
Price/Sales 17.81
Price/Cash Flow N/A
Price/Book 1.50
Book Value/Share 3.56
Interest Coverage -94.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar